Latest News about Biotech and Pharmaceuticals
Recent news which mentions Biotech and Pharmaceuticals
XBB.1.5 omicron subvariant is the most transmissible version of Covid yet, WHO says
January 04, 2023
From CNBC.com News
Highly immune evasive omicron XBB.1.5 variant is quickly becoming dominant in U.S. as it doubles weekly
December 30, 2022
From CNBC.com News
U.S. and global health officials are worried about lack of transparency from China on Covid outbreak
December 29, 2022
From CNBC.com News
UK says no plans for Covid tests for China arrivals as Europe is pressured to tighten rules
December 29, 2022
From CNBC.com News
U.S. will require airline passengers traveling from China to test negative for Covid
December 28, 2022
From CNBC.com News
U.S. records 100 million Covid cases but more than 200 million Americans have probably had it
December 28, 2022
From CNBC.com News
Supreme Court extends Trump-era pandemic immigration rule to allow quicker deportations
December 27, 2022
From CNBC.com News
Millions at risk of losing Medicaid in the spring under provision tucked inside $1.7 trillion federal spending bill
December 21, 2022
From CNBC.com News
Drug overdose deaths among teenagers surged during the pandemic driven by illicit fentanyl
December 19, 2022
From CNBC.com News
Omicron boosters are 84% effective at keeping seniors from being hospitalized with Covid, CDC says
December 16, 2022
From CNBC.com News
How this millennial CEO steered the world's largest vaccine maker during the pandemic
December 16, 2022
From CNBC.com News
Most nursing home residents haven't had omicron booster ahead of expected winter Covid wave
December 15, 2022
From CNBC.com News
Growing obesity crisis in U.S. prompts CDC to expand body mass index charts for severely overweight kids
December 15, 2022
From CNBC.com News
Biden administration makes at-home Covid tests available for free again this winter
December 15, 2022
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.